Shares of the medical device maker Boston Scientific Corp. declined Tuesday, a day after the company said it had agreed to buy Rhythmia Medical Inc., a Burlington developer of medical software. Boston Scientific will pay about $90 million upfront and make as much as $175 million in milestone payments over five years. Rhythmia develops mapping and navigation software for use in cardiac catheter ablations, a way to treat abnormal heart rhythms, and other electrophysi0logy procedures, including atrial fibrillation and atrial flutter.
October 10, 2012
Read it all, now.
Don't miss any of your favorite stories again. Read the stories that matter to you as much as you want, whenever you want when you subscribe to BostonGlobe.com.
Get full access today for just 99¢